|
|
| (11) | Number of the document | C 1606261 |
| (68) | Number of the document | 1606261 |
| (21) | Application number for Supplementary Protection Certificate | PA 2010 010 |
| (22) | Date of filing the application | 2010-07-19 |
| (41) | Date of publication of the application | 2010-08-25 |
| Date of publication of SPC | 2011-03-25 | |
| (24) | Date of coming into effect of SPC | 2024-03-09 |
| (71) |
Nycomed GmbH,
Byk-Gulden-Strasse 2, 78467 Konstanz,
DE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/10/636/001-003, 2010-07-05 |
| (94) | 2025-07-05 |
| (95) | Roflumilastum |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 347.00 EUR |
| SPC expired |